Description

Ethyl 6-Bromo-4-oxo-3,4-dihydro-2H-benzo[e][1,3]oxazine-2-carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its unique benzo[e][1,3]oxazine core structure. This compound is critical for research and development in medicinal chemistry, serving as a versatile building block for the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily utilized by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers focused on developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex heterocyclic compounds with potential biological activity.
• Medicinal Chemistry Research: Used as a scaffold for designing and optimizing new drug candidates in discovery programs.
• API Development: Serves as a building block in the multi-step synthesis of potential Active Pharmaceutical Ingredients (APIs).
• Chemical Biology Probes: Can be utilized to create molecular probes for studying enzyme mechanisms or biological pathways.
• Academic Research: Employed in university and institutional labs for synthetic methodology development and heterocyclic chemistry studies.
• Custom Synthesis: A starting material for contract manufacturing organizations (CMOs) producing bespoke compounds for client projects.

Basic Information

Product Name	Ethyl 6-Bromo-4-oxo-3,4-dihydro-2H-benzo[e][1,3]oxazine-2-carboxylate
CAS No.	30482-66-7
Molecular Formula	C11H10BrNO4
Molecular Weight	300.11 g/mol
Synonyms	Ethyl 6-bromo-4-oxo-2H-benzo[e][1,3]oxazine-2-carboxylate; 2H-Benzo[e][1,3]oxazine-2-carboxylic acid, 6-bromo-3,4-dihydro-4-oxo-, ethyl ester; 6-Bromo-4-oxo-3,4-dihydro-2H-1,3-benzoxazine-2-carboxylic acid ethyl ester; Ethyl 6-bromo-4-oxo-3,4-dihydro-2H-1,3-benzoxazine-2-carboxylate; 30482-66-7; Benzo[e][1,3]oxazine-2-carboxylate derivative
EINECS	Contact for details

Quality Control

Our Ethyl 6-Bromo-4-oxo-3,4-dihydro-2H-benzo[e][1,3]oxazine-2-carboxylate is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and IR spectroscopy, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability and consistency for your critical R&D applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to protect this moisture-sensitive material.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.